Xilong Scientific Co., Ltd. (SHE:002584)

Xilong Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	738.91	593.21	559.89	691.01	769.86	724.8
Trading Asset Securities	-	0.11	-	299.65	61.44	153
Cash & Short-Term Investments	738.91	593.32	559.89	990.66	831.3	877.8
Cash Growth	53.06%	5.97%	-43.48%	19.17%	-5.30%	-27.89%
Accounts Receivable	1,898	1,666	1,637	1,450	1,189	1,271
Other Receivables	15.12	65.48	83.99	278.16	520.58	31.22
Receivables	1,914	1,732	1,721	1,728	1,709	1,302
Inventory	764.08	620.3	561.66	508.2	454.42	713.34
Prepaid Expenses	-	0.01	0.03	0.67	0.2	0.08
Other Current Assets	311.61	342.29	486.84	460.11	704.38	401.34
Total Current Assets	3,728	3,288	3,329	3,688	3,699	3,295
Property, Plant & Equipment	833.47	827.54	845.7	691.6	489.93	513.13
Long-Term Investments	340.96	361.88	369.85	368.41	152.05	145.86
Goodwill	-	-	-	6.54	375.3	375.3
Other Intangible Assets	169.64	180.21	179.43	123.75	62.53	64.47
Long-Term Accounts Receivable	2.73	2.73	2.73	-	-	-
Long-Term Deferred Tax Assets	20.62	13.87	11.48	12.13	8.13	9.91
Long-Term Deferred Charges	25.91	31.26	9.29	35.43	17.41	11.47
Other Long-Term Assets	22.07	10.31	21.22	54.4	5.6	6.57
Total Assets	5,144	4,716	4,769	4,980	4,810	4,421
Accounts Payable	1,151	988	950.26	1,178	1,362	1,156
Accrued Expenses	9.34	51.98	46.87	53.04	61.17	52.97
Short-Term Debt	640.59	634.51	726.17	750.09	512.1	752.38
Current Portion of Long-Term Debt	114.55	124.06	155.83	66.46	114.27	-
Current Portion of Leases	-	5.85	9.43	1.72	7.11	-
Current Income Taxes Payable	79.61	13.29	5.98	8.28	3.65	31.83
Current Unearned Revenue	46.92	44.03	30.41	41.75	37.01	38.37
Other Current Liabilities	321.72	125.84	144.8	242.8	294.39	120.55
Total Current Liabilities	2,364	1,988	2,070	2,342	2,392	2,152
Long-Term Debt	398.47	375.29	319.09	280.03	94.98	174.91
Long-Term Leases	7.54	3.58	6.05	19.4	14.12	-
Long-Term Unearned Revenue	45.02	27.69	12.87	13.72	2.82	4.04
Long-Term Deferred Tax Liabilities	4.02	2.57	7.2	8.02	-	2.17
Other Long-Term Liabilities	77.05	13.11	-	-	-	-
Total Liabilities	2,896	2,410	2,415	2,663	2,504	2,333
Common Stock	585.22	585.22	585.22	585.22	585.22	585.22
Additional Paid-In Capital	682.38	682.38	682.38	682.38	682.38	669.34
Retained Earnings	926.93	988.76	1,032	999.15	911.06	722.66
Comprehensive Income & Other	47.68	43.4	47.9	43.83	46.91	39.38
Total Common Equity	2,242	2,300	2,348	2,311	2,226	2,017
Minority Interest	5.74	6.03	6.06	5.8	80.81	71.58
Shareholders' Equity	2,248	2,306	2,354	2,316	2,306	2,088
Total Liabilities & Equity	5,144	4,716	4,769	4,980	4,810	4,421
Total Debt	1,161	1,143	1,217	1,118	742.57	927.29
Net Cash (Debt)	-422.24	-549.96	-656.68	-127.04	88.73	-49.49
Net Cash Per Share	-0.75	-0.98	-1.18	-0.21	0.17	-0.09
Filing Date Shares Outstanding	585.22	585.22	585.22	585.22	585.22	585.22
Total Common Shares Outstanding	585.22	585.22	585.22	585.22	585.22	585.22
Working Capital	1,365	1,300	1,260	1,345	1,307	1,143
Book Value Per Share	3.83	3.93	4.01	3.95	3.80	3.45
Tangible Book Value	2,073	2,120	2,169	2,180	1,788	1,577
Tangible Book Value Per Share	3.54	3.62	3.71	3.73	3.05	2.69
Buildings	-	587.12	596.4	472.95	447.59	452.04
Machinery	-	393.87	241.28	205.2	176.27	197.38
Construction In Progress	-	68.24	207.89	185.53	12.77	41.36

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.